VC  Kearny Venture Partners

http://www.kearnyvp.com





     Office Locations:

88 Kearny Street, 2nd Floor
San Francisco, CA 94108-5530
Phone: 415-364-5999
Fax: 415-364-6944

 

Stages:

  • Early
  • Expansion
  • Growth
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    With over $330 million in capital under management, Kearny Venture Partners is a venture capital firm exclusively focused on healthcare products. Kearny Venture Partners focuses on investments in the following areas of healthcare: medical devices and drugs (both small molecules and biopharmaceuticals). The firm is willing to invest in companies at many stages. From founding companies and formation rounds to later stage investments in well-established companies, the firm's typical first investment ranges from $2-8 million. Ultimately, Kearny seeks to invest $10-15 million per company. Kearny Venture Partners is the successor to two prior limited partnerships managed under the titles of ABS Ventures HC and Thomas Weisel Healthcare.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Andrew Jensen Chief Financial Officer
    Anupam Dalal MD Managing Director
    Caley Castelein MD Managing Director
    David Bradford Venture Partner
    Dick Spalding Managing Director

     

    Portfolio companies include:


      Aerpio Therapeutics
        web link


      Akebia Therapeutics
        web link


      Align Technology
        web link


      Appriva Medical
        web link


      Aspreva
        web link


      Baxano
        web link


      Boreal Genomics
        web link


      Cotherix


      CVRx
        web link


      eValve
        web link


      eyeonics
        web link


      Foxhollow
        web link


      Hansen Medical
        web link


      Intact
        web link


      KAI
        web link


      LuMend
        web link


      NextWave
        web link


      QUATRx
        web link


      Rib-X
        web link


      Satiety


      SpinalMotion
        web link


      Tandem Diabetes
        web link


      Theravance
        web link


      Trans1
        web link


      TriVascular
        web link


      Viewray
        web link


      XTechnologies
        web link


     

    Recent News: